Browsing Category

Immune Therapy

Showing 7 Result(s)
Autoimmune Disease Autoimmune Monitoring Bioengineering Biomarker Brain Research Chronic Autoimmune Disease Chronic Autoimmune Disorder Epilepsy Genetic Research Immune Deficiency Disorders Immune Dysfunction Immune Suppressed Immune System Immune System Impairment Immune Therapy Immune Thrombocytopenia (ITP) Immunology Immunomodulatory Drugs MS MS Fatigue MS Relapse MS Team MS Unfiltered Multiple myeloma Multiple Sclerosis Multiple Sclerosis (MS) Multiple Sclerosis Education Neurodegenerative Disease Neurodevelopment Disorder Neurodivergent Entrepreneur Neuroendocrine tumours Neurogenesis Neuroimaging Neurological Disorders Neurologist Neurology Neuron Receptors Neurons Neuropathy Neuropsychiatric Symptoms Neuroscience Neurotransmitters NHS Primary Progressive MS (PPMS) Serum Biobanks

Professor Neil Robertson: Leading Neurologist and Researcher

Professor Neil Robertson’s contributions to neurology and neurological research have not only advanced our understanding of complex disorders like multiple sclerosis but also shaped the landscape of neurological healthcare in Wales and beyond. His research and clinical work represent a commitment to both scientific discovery and compassionate care, offering hope to patients and families affected by neurological conditions. As he continues to lead new studies and mentor future neurologists, his impact will undoubtedly continue to be felt across the fields of neurology, genetics, and patient advocacy.

'Mr Tibbles' The MS Cat Reporter Alemtuzumab Autoimmune Disease Autoimmune Monitoring B Cells Blood Brain Barrier Brain Infection Central Nervous System (CNS) Chronic Autoimmune Disease Chronic Autoimmune Disorder Chronic kidney disease Cognitive Impairment Death Dimethyl Fumarate (Tecfidera) Disability UK Disabled Fingolimod (Gilenya) HIV HIV/AIDS Immune Deficiency Disorders Immune Dysfunction Immune Suppressed Immune System Immune System Impairment Immune Therapy Immune Thrombocytopenia (ITP) Immunomodulatory Drugs Infusion Treatment JC (John Cunningham) virus Lemtrada Lumbar Puncture Lymph Nodes lymphocytes Magnetic Resonance Imaging (MRI) MS MS Fatigue MS Relapse MS Team MS Unfiltered Multiple Sclerosis Multiple Sclerosis (MS) Multiple Sclerosis Education Myelin Myelin Sheath Natalizumab (Tysabri) Nerve Cells Neurodegenerative Disease Neurodevelopment Disorder Neurological Disorders Neurologist Neurology Ocrelizumab (Ocrevus) Paralysis Pediatric Autoimmune Neuropsychiatric Disorder (PANDAS) Plasma Exchange Primary Progressive MS (PPMS) Progressive Multifocal Leukoencephalopathy (PML) Seizures Speech Difficulties Visual Impairment www.disabilityuk.co.uk www.disabilityuk.org www.disabledentrepreneur.uk Zena's Online Journal

Progressive Multifocal Leukoencephalopathy (PML)

Progressive Multifocal Leukoencephalopathy (PML) is a severe, life-threatening condition that poses a particular risk for MS patients using immunosuppressive therapies. Awareness of the risk factors, regular monitoring, and open communication with healthcare providers are essential for MS patients considering or currently using these medications.

Access Accessibility Accessibility & Inclusion Accessibility Tools Accessibility Tours AI Assistant Aromatherapy Art Therapy Assistive Technology Benefits Beta Cell Replacement Therapy Cell & Gene Therapy Cell & Gene Therapy AI Chemotherapy Cognitive Behavioral Therapy Cognitive Rehabilitation Therapy (CRT) Creative Therapy Department Work & Pensions (DWP) Dialectical Behavior Therapy (DBT) Disabilities Virtual Assistant Disability Benefits Disability Discrimination Disability Law Disability Living Allowance (DLA) Disability Modified Housing Disability Services Disability Support Disability Travel Disability UK Disabled Disabled Entrepreneur Disease-Modifying therapies (DMTs) DWP DWP Complaints DWP Sanctions Energy Bills Energy Poverty Energy Providers Energy Tariffs Essential Aids Financial Difficulty Financial Hardship Financial Planning Financial Support Gardening Therapy Gene Therapy AI Graded Exercise Therapy (GET) Hearing Aids Heliotherapy Immune Therapy Memory Aids Mentalization-Based Therapy (MBT) Mobility Mobility Aids Mobility Allowance Mobility Impairment NHS NHS Reform Occupational Therapists Online Therapy Oxygen Therapy Personal Indpendence Payments Physical Therapy Physiotherapists Physiotherapy PIP PIP Appeals PIP Assessments PIP Award PIP Complaints PIP Eligibility PIP Guidlines PIP Reform PIP Tribunal Policies Policymakers Politicians Politics Psychedelic Therapy Psychological Therapy Psychotherapy Restaurant Accessibility Self Driving Wheelchairs Self Help Therapy Shopping Mall Accessibility Sleep Aids Sport Therapy State Benefits Stem Cell Therapy Sun Therapy Therapy & Counselling UK Market Research Utility Companies Vitamin Therapy Voice Activated Assistants Welfare Welfare Reform Welfare Reform Act 2012 Welsh Government www.disabilityuk.co.uk www.disabilityuk.org www.disabledentrepreneur.uk www.dyslexiaai.co.uk www.genetherapyai.com www.ukmarketresearch.co.uk

Taxpayer Survey: Re PIP Payments

The wide array of essential expenses that PIP covers for people with disabilities illustrates the importance of maintaining cash payments. A voucher-based system would struggle to address the individualized needs associated with disability-related costs, from specialized medical devices to unique dietary requirements.

Acute Distress Anxiety Autoimmune Disease Chronic Anxiety Chronic fatigue syndrome Chronic Stress Clinical Depression Cognitive Function Cognitive Impairment Depression Emotional Distress Endorphins Excercise Fatigue GAD Generalized Anxiety Disorder Heliotherapy Immune Deficiency Disorders Immune Dysfunction Immune Suppressed Immune System Immune System Impairment Immune Therapy Lesions Major Depressive Disorder (MDD) Manic Depression Mental Health Education Mental Health Support Mental Health Wales Mobility MS MS Team Multiple Sclerosis Multiple Sclerosis (MS) Neurology Pediatric Autoimmune Neuropsychiatric Disorder (PANDAS) Serotonin Serotonin Reuptake Inhibitors (SSRIs) Skin Lesions Stress Stress, anxiety and low mood Sun Protection Sun Therapy Sunbathing Sunburn Vision Vitamin D Vitamin D Deficiency Zena's Online Journal

Sun Therapy and Multiple Sclerosis

Research has shown that people living in regions farther from the equator, where there is less sunlight exposure, have a higher incidence of MS. This geographical distribution suggests a link between vitamin D deficiency and the risk of developing MS.

Autoimmune Disease Central Nervous System (CNS) Cognitive Function Cognitive Impairment Epstein-Barr Virus (EBV) Glandular fever Herpes Virus Immune Deficiency Disorders Immune Suppressed Immune System Immune Therapy Immune Thrombocytopenia (ITP) Kissing Disease Mononucleosis (Mono) MS Multiple Sclerosis Multiple Sclerosis (MS) Muscle Stiffness Muscle Weakness Myelin Sheath Uncategorized Vitamin D Vitamin D Deficiency

The Link Between Epstein-Barr virus, Location & MS

Multiple sclerosis (MS) is a chronic autoimmune disease that affects the central nervous system, leading to symptoms such as muscle weakness, coordination problems, and cognitive impairments.

ADHD Anxiety Attention deficit hyperactivity disorder (ADHD) Autoimmune Disease Awareness Campaign CBT Chronic Anxiety Chronic Stress Cognitive Behavioral Therapy Emotional Distress GAD Generalized Anxiety Disorder Germ Awareness Health Awareness Immune Therapy Mental Health Mental Health Campaigns Mental Health Disabilities Mental Health Support Mental Health Wales Mood Disorders Mood Swings National Institute of Mental Health (NIMH) Neurological Disorders Neuropsychiatric Symptoms Obsessive Compulsive Disorder OCD OCD Campaigns OCD Cymru Panic Attacks Panic disorder Pediatric Autoimmune Neuropsychiatric Disorder (PANDAS) Post-Traumatic Stress Disorder Post-traumatic stress disorder (PTSD) Psychology Psychotherapy Psychotic Disorders Serotonin Serotonin Reuptake Inhibitors (SSRIs) Spreading Awareness Streptococcal Infections Streptococcus A (strep A) Stress Stress, anxiety and low mood Teenager Mental Health Support www.germawareness.co.uk www.ocd.cymru Young Persons Mental Health Support

Pediatric Autoimmune Neuropsychiatric Disorder (PANDAS) and OCD

Understanding PANDAS and its connection to OCD not only aids in the effective treatment of affected children but also provides a broader insight into the ways in which immune responses can impact mental health. As research progresses, it is hoped that more definitive answers and improved therapeutic options will emerge, further bridging the gap between physical and mental health in pediatric care.

Autoimmune Disease Chronic pain Cramps Immune Therapy Leg cramps Muscle Stiffness Neurological Disorders Physical Therapy Spasms

Understanding Stiff Person Syndrome

Stiff Person Syndrome (SPS) is a rare and often debilitating neurological disorder characterized by progressive muscle stiffness and painful spasms. First identified in the 1950s, SPS affects approximately one in a million people. Despite its rarity, understanding its impact on daily life and available treatments is crucial for those affected and their caregivers.